Treatment of patients hemophilics with an inhibitor
Gormsen, J.
Sangre 24(5-C): 990-992
1979
ISSN/ISBN: 0036-4355 PMID: 121171 Document Number: 151579
Document emailed within 1 workday
Related Documents
Julien, M. 1971: Surgery of the digestive system in hemophilics Annales de Chirurgie 25(15): 817-827Piroth, L.; Grappin, M.; Waldner, A.; Sgro, C.; Duong, M.; Buisson, M.; Chavanet, P.; Portier, H. 1999: Discontinuing protease inhibitor treatment of HIV-1 patients for intolerance. Longitudinal study of 309 patients Presse Medicale 28(8): 381-387
Libánský, J. 1970: Care of hemophilics in Czechoslovakia. (A medico-sociological study) Vnitrni Lekarstvi 16(1): 11-20
Bolten, W.W. 2003: In high risk patients cyclooxygenase inhibitor plus proton pump inhibitor MMW Fortschritte der Medizin 145(5): 9
Giannini, S.D.; de Góes, J.M.; Dereviack, B.E.; Machado, C.; Forti, N.; Diament, J. 1990: Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis Arquivos Brasileiros de Cardiologia 54(6): 407-414
Ritt, M.J.; Hillebrand-Haverkort, M.E.; ten Veen, J.H. 2001: Local treatment of facial lipodystrophy in patients receiving HIV protease inhibitor therapy Acta Chirurgiae Plasticae 43(2): 54-56
Terranova, R.; Luca, S. 1993: Treatment with an aldose reductase inhibitor in peripheral neuropathy in elderly diabetic patients Minerva Medica 84(9): 461-466
Della Porta, P.; Soeltl, R.; Krell, H.W.; Collins, K.; O'Donoghue, M.; Schmitt, M.; Krüger, A. 1999: Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo Anticancer Research 19(5b): 3809-3816
Kalisvaart, C.J.; Boelaarts, L.; de Jonghe, J.F.M.; Hovinga, I.M.; Kat, M.G. 2004: Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine Nederlands Tijdschrift Voor Geneeskunde 148(30): 1501-1504
Gelderblom, H.; Hogendoorn, P.C.; van der Graaf, W.T.; Verweij, J. 2003: Imatinib, a specific tyrosine-kinase inhibitor, for the treatment of patients with a gastrointestinal stroma cell tumor Nederlands Tijdschrift Voor Geneeskunde 147(42): 2051-2055
Tizzani, A.; Casetta, G.; Giona, C.; Piana, P.; Frea, B. 1986: Use of a urease inhibitor, propionohydroxamic acid, in the treatment and prevention of infectious renal lithiasis. A study of 19 patients Minerva Urologica e Nefrologica 38(3): 239-249
Vorob'eva, N.M.; Panchenko, E.P.; Dobrovol'skiĭ, A.B.; Titaeva, E.V.; Ermolina, O.V.; Balakhonova, T.V.; Khasanova, Z.B.; Postnov, A.I.; Kirienko, A.I. 2011: Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications Terapevticheskii Arkhiv 83(12): 43-48
Okada, S.; Ishii, K.; Tanokuchi, S.; Hamada, H.; Ichiki, K.; Ota, Z. 1995: Effect of an alpha-glucosidase inhibitor combined with sulphonylurea treatment on glucose metabolism in patients with non-insulin-dependent diabetes mellitus Journal of International Medical Research 23(4): 279-283
Mitichkina, E.V.; Morozov, S.G.; Zakharova, I.A.; Volkova, E.N.; Elistratova, I.V. 2014: Leukocyte elastase, alpha 1-proteinase inhibitor and C-reactive protein in patients with delayed negativation of serological reactions after treatment of early syphilis Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 8-12
Koyama, H.; Iesato, A.; Fukushima, Y.; Okada, T.; Watanabe, T.; Harada, M.; Ito, T.; Maeno, K.; Mochizuki, Y.; Ito, K.; Amano, J. 2011: A retrospective study of high-dose toremifene treatment for patients with aromatase inhibitor refractory advanced or metastatic hormone receptor-positive breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(7): 1123-1126
Laurell, M.; Stenflo, J. 1989: Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein Thrombosis and Haemostasis 62(3): 885-891
Sherman, K.E.; Shire, N.J.; Cernohous, P.; Rouster, S.D.; Omachi, J.H.; Brun, S.; Da Silva, B. 2005: Liver injury and changes in hepatitis C virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients : Lopinavir-ritonavir versus nelfinavir Clinical Infectious Diseases 41(8): 1186-1195
Gianotti, N.; Poli, A.; Galli, M.; Pan, A.; Rizzardini, G.; Soria, A.; Viale, P.; Di Biagio, A.; Quirino, T.; Viganò, P.; Bonfanti, P.; d'Arminio Monforte, A.; Fortino, I.; Lazzarin, A. 2014: Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study New Microbiologica 37(4): 439-448
Gaillard, M.C.; Reichberg, S.B.; Nogueira, C.M.; Kilroe-Smith, T.A. 1993: Differences in elastase-binding activity of alpha 1-protease inhibitor and alpha 2-macroglobulin for asthma patients and control subjects with various alpha 1-protease inhibitor phenotypes Clinical Chemistry 39(4): 675-679
Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385